We fight to improve the lives
of everyone affected by epilepsy

Warning message

  • This article was published in June 2016. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in February 2016. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in January 2015. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in December 2014. The information may be out of date. Please check our epilepsy information or our site A-Z.

Stories about children

Answering some questions about childhood epilepsy to mark Purple Day 2019

26 Mar 2019

For over 10 years, on 26 of March we have marked Purple Day, the international epilepsy awareness day. This is always a powerful day, full of unity, inspiration and information. It allows people to show their support for everyone living with epilepsy, share their experiences of the condition and raise some money and awareness.

Lacosamide epilepsy medicine approved for use in children over 4 years old with focal-onset seizures

29 Sep 2017

Pharmaceutical company UCB’s lacosamide epilepsy medicine, known as VIMPAT, has been approved by the European Commission for use in children over 4 years old in Europe.

The lacosamide medicine was approved in September for use on its own or alongside other medicines to treat focal-onset seizures. It was previously approved for use in teenagers over 16 years old and adults in Europe.

Pages

Subscribe to children